This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Funaki, M. Articles by Janmey, P. A. Search for Related Content PubMed PubMed Citation Articles by Funaki, M. Articles by Janmey, P. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2004, p. 7567-7577, Vol. 24, No. 17
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.17.7567-7577.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Separation of Insulin Signaling into Distinct GLUT4 Translocation and Activation Steps

Department of Physiology, Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, Pennsylvania

Received 15 October 2003/ Returned for modification 26 November 2003/ Accepted 28 May 2004

GLUT4 (glucose transporter 4) plays a pivotal role in insulin-induced glucose uptake to maintain normal blood glucose levels. Here, we report that a cell-permeable phosphoinositide-binding peptide induced GLUT4 translocation to the plasma membrane without inhibiting IRAP (insulin-responsive aminopeptidase) endocytosis. However, unlike insulin treatment, the peptide treatment did not increase glucose uptake in 3T3-L1 adipocytes, indicating that GLUT4 translocation and activation are separate events. GLUT4 activation can occur at the plasma membrane, since insulin was able to increase glucose uptake with a shorter time lag when inactive GLUT4 was first translocated to the plasma membrane by pretreating the cells with this peptide. Inhibition of phosphatidylinositol (PI) 3-kinase activity failed to inhibit GLUT4 translocation by the peptide but did inhibit glucose uptake when insulin was added following peptide treatment. Insulin, but not the peptide, stimulated GLUT1 translocation. Surprisingly, the peptide pretreatment inhibited insulin-induced GLUT1 translocation, suggesting that the peptide treatment has both a stimulatory effect on GLUT4 translocation and an inhibitory effect on insulin-induced GLUT1 translocation. These results suggest that GLUT4 requires translocation to the plasma membrane, as well as activation at the plasma membrane, to initiate glucose uptake, and both of these steps normally require PI 3-kinase activation.

This article has been cited by other articles:

• Ning, Y., Schuller, A. G. P., Bradshaw, S., Rotwein, P., Ludwig, T., Frystyk, J., Pintar, J. E. (2006). Diminished Growth and Enhanced Glucose Metabolism in Triple Knockout Mice Containing Mutations of Insulin-Like Growth Factor Binding Protein-3, -4, and -5. Mol. Endocrinol. 20: 2173-2186 [Abstract] [Full Text]  
• Kong, A. M., Horan, K. A., Sriratana, A., Bailey, C. G., Collyer, L. J., Nandurkar, H. H., Shisheva, A., Layton, M. J., Rasko, J. E. J., Rowe, T., Mitchell, C. A. (2006). Phosphatidylinositol 3-Phosphate [PtdIns(3)P] Is Generated at the Plasma Membrane by an Inositol Polyphosphate 5-Phosphatase: Endogenous PtdIns(3)P Can Promote GLUT4 Translocation to the Plasma Membrane.. Mol. Cell. Biol. 26: 6065-6081 [Abstract] [Full Text]  
• Mari, M., Monzo, P., Kaddai, V., Keslair, F., Gonzalez, T., Le Marchand-Brustel, Y., Cormont, M. (2006). The Rab4 effector Rabip4 plays a role in the endocytotic trafficking of Glut 4 in 3T3-L1 adipocytes. J. Cell Sci. 119: 1297-1306 [Abstract] [Full Text]  
• Thong, F. S. L., Dugani, C. B., Klip, A. (2005). Turning Signals On and Off: GLUT4 Traffic in the Insulin-Signaling Highway. Physiology 20: 271-284 [Abstract] [Full Text]  
• Ribe, D., Yang, J., Patel, S., Koumanov, F., Cushman, S. W., Holman, G. D. (2005). Endofacial Competitive Inhibition of Glucose Transporter-4 Intrinsic Activity by the Mitogen-Activated Protein Kinase Inhibitor SB203580. Endocrinology 146: 1713-1717 [Abstract] [Full Text]  
• Tremblay, F., Gagnon, A., Veilleux, A., Sorisky, A., Marette, A. (2005). Activation of the Mammalian Target of Rapamycin Pathway Acutely Inhibits Insulin Signaling to Akt and Glucose Transport in 3T3-L1 and Human Adipocytes. Endocrinology 146: 1328-1337 [Abstract] [Full Text]